Clarity Pharmaceuticals Ltd (ASX:CU6)
1.835
+0.010 (0.55%)
Nov 17, 2026, 11:19 AM AEDT
Clarity Pharmaceuticals Market Cap
Clarity Pharmaceuticals has a market cap or net worth of 684.6 million as of November 16, 2026. It is the 14,976th most valuable company in the world and the 285th biggest in Australia. Its market cap has decreased by 52.57% in one year.
Market Cap
684.60M
Enterprise Value
506.35M
Revenue
10.53M
Global Rank
Country Rank
#285 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since August 25, 2021, Clarity Pharmaceuticals's market cap has increased from 384.20M to 684.60M, an increase of 78.19%. That is a compound annual growth rate of 11.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 684.60M | -45.56% |
| Dec 31, 2025 | 1.26B | -6.00% |
| Dec 31, 2024 | 1.34B | 168.49% |
| Dec 29, 2023 | 498.26M | 93.82% |
| Dec 30, 2022 | 257.07M | 35.63% |
| Dec 31, 2021 | 189.54M | -50.67% |
| Aug 25, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuren Pharmaceuticals | 2.92B |
| Mesoblast | 2.51B |
| PYC Therapeutics | 1.81B |
| Clinuvel Pharmaceuticals | 374.18M |
| Tetratherix | 339.57M |
| Racura Oncology | 308.81M |
| Starpharma Holdings | 203.89M |
| BLS Pharmaceuticals | 196.91M |